1-13 of 13
Maria T Petrucci
Close
Sort by
Journal Articles

Impact of Complete Response on Survival with Either Autologous Stem Cell Transplantation or Conventional Chemotherapy: Results of a Pooled Analysis of 5 Phase III Trials in Newly Diagnosed Multiple Myeloma Patients

Roberto Mina, Alessandra Larocca, Massimo Offidani, Sara Bringhen, Tommaso Caravita, Valeria Magarotto, MD, Lucia Pantani, MD, Francesco Di Raimondo, Alberto Bosi, Iolanda D. Vincelli, Paola Tacchetti, MD, Gianluca Gaidano, Sonia Grandi, Caterina Musolino, Chiara Cerrato, Ludek Pour, Monica Astolfi, Giuseppe Rossi, MD, Fausto Rossini, Maria T. Petrucci, Roberto Ria, Annalisa Pezzi, PhD, Roman Hajek, Michele Cavo, Andrew Spencer, Mario Boccadoro, MD, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 927.
https://doi.org/10.1182/blood.V126.23.927.927
Published: 2015
Journal Articles

Continued Overall Survival Benefit After 5 Years' Follow-up with Bortezomib-Melphalan-Prednisone (VMP) Versus Melphalan-Prednisone (MP) in Patients with Previously Untreated Multiple Myeloma, and No Increased Risk of Second Primary Malignancies: Final Results of the Phase 3 VISTA Trial

Jesús F San Miguel, MD PhD, Rudolf Schlag, MD, Nuriet K Khuageva, MD, Meletios Athanasios Dimopoulos, MD, Ofer Shpilberg, MD, MPH, Martin Kropff, MD, Ivan Spicka, MD, PhD, Maria T Petrucci, Antonio Palumbo, MD, Olga S Samoilova, MD, Anna Dmoszynska, Kudrat M Abdulkadyrov, Prof, Michel Delforge, MD, PhF, Bin Jiang, María-Victoria Mateos, MD, PhD, Kenneth C. Anderson, MD, Dixie-Lee Esseltine, MD, FRCPC, Kevin Liu, PhD, William M Deraedt, PhD, Andrew Z Cakana, MD, FRCPath, Helgi van de Velde, MD, PhD, Paul G. Richardson, MD
Journal: Blood
Blood (2011) 118 (21): 476.
https://doi.org/10.1182/blood.V118.21.476.476
Published: 2011
Journal Articles

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

Clinical Trials & Observations
Francesca Gay, Alessandra Larocca, Pierre Wijermans, Federica Cavallo, Davide Rossi, Ron Schaafsma, Mariella Genuardi, Alessandra Romano, Anna Marina Liberati, Agostina Siniscalchi, Maria T. Petrucci, Chiara Nozzoli, Francesca Patriarca, Massimo Offidani, Roberto Ria, Paola Omedè, Benedetto Bruno, Roberto Passera, Pellegrino Musto, Mario Boccadoro, Pieter Sonneveld, Antonio Palumbo
Journal: Blood
Blood (2011) 117 (11): 3025–3031.
https://doi.org/10.1182/blood-2010-09-307645
Published: 2011
Journal Articles

Bortezomib, Pegylated-Lyposomal-Doxorubicin and Dexamethasone Followed by Melphalan 100 mg/m 2 in Elderly Newly Diagnosed Patients: An Interim Analysis.

Antonio Palumbo, MD, Ilaria Avonto, MD, Francesca Patriarca, MD, Claudia Crippa, MD, Maria T. Petrucci, MD, Fausto Rossini, MD, Paolo Corradini, MD, Anna M. Liberati, MD, Nicola Giuliani, MD, Norbert Pescosta, MD, Patrizia Falco, MD, Alessandra Larocca, MD, Paola Omedè, MD, Massimo Offidani, MD, Renato Fanin, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 448.
https://doi.org/10.1182/blood.V110.11.448.448
Published: 2007
Journal Articles

ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia

Brief Report
Chiara Gregorj, Maria R. Ricciardi, Maria T. Petrucci, Maria C. Scerpa, Fabiana De Cave, Paola Fazi, Marco Vignetti, Antonella Vitale, Marco Mancini, Giuseppe Cimino, Salvatore Palmieri, Francesco Di Raimondo, Giorgina Specchia, Francesco Fabbiano, Nicola Cantore, Federico Mosna, Andrea Camera, Mario Luppi, Luciana Annino, Eustachio Miraglia, Giuseppe Fioritoni, Francesca Ronco, Giovanna Meloni, Franco Mandelli, Michael Andreeff, Michele Milella, Robin Foà, Agostino Tafuri
Journal: Blood
Blood (2007) 109 (12): 5473–5476.
https://doi.org/10.1182/blood-2006-05-021071
Published: 2007
Includes: Supplemental data
Journal Articles

Effective Targeting of MEK/ERK Signalling at Nanomolar Concentrations by the Novel Small Molecule Inhibitor PD0325901 in Hematopoietic and Solid Tumors.

Maria R. Ricciardi, PhD, Maria C. Scerpa, PhD, Ludovica Ciuffreda, PhD, Sabina Chiaretti, MD, PhD, Simona Tavolaro, PhD, Jacopo Gervasoni, Fabiana De Cave, PhD, Chiara Gregorj, PhD, Maria T. Petrucci, MD, Francesco Cognetti, MD, Michael Andreeff, MD, PhD, Gabriella Zupi, MD, Robin Foà, MD, Agostino Tafuri, MD, Michele Milella, MD
Journal: Blood
Blood (2005) 106 (11): 3370.
https://doi.org/10.1182/blood.V106.11.3370.3370
Published: 2005
Journal Articles

Role of Extracellular Signal-Regulated Kinase-1/2 (ERK) on Complete Remission Achievement of Primary Adult Acute Lymphoblastic Leukemia Patients Enrolled in the GIMEMA Protocol LAL 2000: In Vitro Activity of the MEK Inhibithor PD98059.

Chiara Gregorj, PhD, Maria T. Petrucci, MD, Maria C. Scerpa, PhD, Maria R. Ricciardi, PhD, Fabiana De Cave, PhD, Jacopo Gervasoni, Marco Vignetti, MD, Stefania Gubbiotti, MSC, Cristina Ariola, Giorgina Specchia, MD, Annalisa Chiarenza, MD, Felicetto Ferrara, MD, Francesco Fabbiano, MD, Andrea Camera, MD, Giuseppe Fioritoni, MD, Eustachio Miraglia, MD, Luciana Annino, MD, Federico Mosna, MD, Nicola Cantore, MD, Mario Luppi, MD, Francesco Nobile, MD, Giuseppe Leone, MD, Lorella Depaoli, MD, Antonio Peta, MD, Massimo A. Martelli, MD, Ignazio Majolino, MD, Marco Montanaro, MD, Michele Milella, MD, Giovanna Meloni, MD, Robert Foà, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2005) 106 (11): 853.
https://doi.org/10.1182/blood.V106.11.853.853
Published: 2005
Journal Articles

Breast Cancer Resistance Protein (BCRP) Expression Affects Event-Free Survival in Adult Acute Lymphoblastic Leukemia Patients Uniformly Treated According to the GIMEMA LAL 2000 Protocol.

Chiara Gregorj, PhD, Maria T. Petrucci, MD, Fabiana De Cave, PhD, Maria C. Scerpa, PhD, Maria R. Ricciardi, PhD, Jacopo Gervasoni, Maria L. Iannitto, Marco Vignetti, MD, Paola Fazi, MD, Antonella Vitale, MD, Giovanna Meloni, MD, Vincenzo Liso, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Francesco Fabbiano, MD, Andrea Camera, MD, Giuseppe Fioritoni, MD, Eustachio Miraglia, MD, Luciana Annino, MD, Nicola Cascavilla, MD, Filippo Marmont, MD, Patrizio Mazza, MD, Omar Perbellini, MD, Nicola Cantone, MD, Mario Luppi, MD, Francesco Nobile, MD, Simona Sica, MD, Flavia Salvi, MD, Robin Foa’, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2005) 106 (11): 854.
https://doi.org/10.1182/blood.V106.11.854.854
Published: 2005
Journal Articles

Long Term Follow-Up of 198 IgM Monoclonal Gammopathy of Undetermined Significance (MGUS).

Ombretta Annibali, MD, Maria T. Petrucci, MD, Francesco Bartolozzi, MD, Anna Levi, MD, Patrizia Del Bianco, BSc, Cristiano Gallucci, MD, Robin Foa, MD, Franco Mandelli, MD, Giuseppe Avvisati, MD.PhD
Journal: Blood
Blood (2004) 104 (11): 4859.
https://doi.org/10.1182/blood.V104.11.4859.4859
Published: 2004
Journal Articles

Natural History of 656 Patients with Non IgM MGUS.

Carolina Nobile, MD, Maria T. Petrucci, MD, Francesco Bartolozzi, MD, Anna Levi, MD, Marianna De Muro, MD, Maria C. Tirindelli, MD, Patrizia Del Bianco, BSc, Cristiano Gallucci, MD, Franco Mandelli, MD, Giuseppe Avvisati, MD
Journal: Blood
Blood (2004) 104 (11): 4860.
https://doi.org/10.1182/blood.V104.11.4860.4860
Published: 2004
Journal Articles

Cytokines Behaviour in Multiple Myeloma during Zoledronic Acid Treatment.

Giuseppe Avvisati, MD, PhD, Maria T. Petrucci, MD, Ombretta Annibali, MD, Francesco Bartolozzi, MD, Barbara Giannetti, BSc, Anna Levi, MD, Fabrizio Battistoni, BSc, Michele Gavasci, BSc, Giordano Dicuonzo, MD, Bruno Vincenzi, MD, Daniele Santini, MD, Robin Foa, MD, Franco Mandelli, MD
Journal: Blood
Blood (2004) 104 (11): 4913.
https://doi.org/10.1182/blood.V104.11.4913.4913
Published: 2004
Journal Articles

Breast Cancer Resistance Protein (BCRP) in Adult Acute Lymphoblastic Leukemia Patients.

Chiara Gregorj, PhD, Agostino Tafuri, MD, Maria T. Petrucci, MD, Maria C. Scerpa, PhD, Fabiana De Cave, PhD, Maria R. Ricciardi, Ph, Antonella Vitale, MD, Francesca Paoloni, BSc, Robin Foa, MD
Journal: Blood
Blood (2004) 104 (11): 1897.
https://doi.org/10.1182/blood.V104.11.1897.1897
Published: 2004
Journal Articles

MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia

Agostino Tafuri, Chiara Gregorj, Maria T. Petrucci, Maria R. Ricciardi, Marco Mancini, Giuseppe Cimino, Cristina Mecucci, Alessandra Tedeschi, Giuseppe Fioritoni, Felicetto Ferrara, Francesco Di Raimondo, Eugenio Gallo, Vincenzo Liso, Francesco Fabbiano, Nicola Cascavilla, Giovanni Pizzolo, Andrea Camera, Fabrizio Pane, Francesco Lanza, Daniela Cilloni, Luciana Annino, Antonella Vitale, Maria L. Vegna, Marco Vignetti, Robin Foà, Franco Mandelli
Journal: Blood
Blood (2002) 100 (3): 974–981.
https://doi.org/10.1182/blood-2001-12-0371
Published: 2002